Literature DB >> 12624786

Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein.

Shinsuke Kato1, Hiroyasu Esumi, Asao Hirano, Masako Kato, Kohtaro Asayama, Eisaku Ohama.   

Abstract

In this study, inducible nitric oxide synthase (iNOS) expression in a series of 158 human primary brain tumors was analyzed. To gain some insight into the biological significance of iNOS expression in tumor cells, comparative immunohistochemical analyses were employed to characterize the expression of iNOS, superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein in these cells. Sixteen (39.0%) of the 41 glioblastoma multiforme (GBM) specimens showed iNOS immunoreactivity. Positive immunoreactions with iNOS were also detected in 2/8 anaplastic astrocytomas, 1/17 astrocytomas, 1/14 medulloblastomas and 1/11 primitive neuroectodermal tumors, but no positive reactions were observed in oligodendrogliomas (0/11), ependymomas (0/5), schwannomas (0/21), meningiomas (0/23) or pituitary adenomas (0/7). The MIB-1 labeling index of GBMs that expressed iNOS was significantly higher than that of GBMs that did not (0.025< P <0.05, Wilcoxon rank-sum test). Unlike iNOS-negative tumors, all iNOS-positive tumors coexpressed SOD1 or SOD2. In particular, there was a significant correlation between iNOS induction and SOD1 expression (P =1.65x10(-10), Fisher's exact test) in GBM specimens. There was no significant relationship between iNOS and p53 protein in any type of primary brain tumor (P >0.05, Fisher's exact test). No significant immunohistochemical reactions with iNOS, MIB-1 or p53 protein were observed in normal brain tissue sections. We conclude that primary brain tumors express iNOS, and that iNOS expression in brain tumor cells may depend, in part, on cellular proliferation potential. Based on the fact that SOD1 scavenges oxidative-stress species originating from large amounts of nitric oxide (NO) produced by iNOS, iNOS-expressing brain tumor cells may protect themselves against NO cytotoxicity by overinducing SOD1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12624786     DOI: 10.1007/s00401-002-0646-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  Cerebellar expression of copper chaperone for superoxide, cytosolic cu/zn-superoxide dismutase, 4-hydroxy-2-nonenal, acrolein and heat shock protein 32 in patients with menkes kinky hair disease: immunohistochemical study.

Authors:  Atsushi Yokoyama; Kousaku Ohno; Asao Hirano; Masayuki Shintaku; Masako Kato; Kazuhiko Hayashi; Shinsuke Kato
Journal:  Yonago Acta Med       Date:  2014-04-28       Impact factor: 1.641

Review 2.  Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macrophages, and possible therapeutic implications: a comprehensive review.

Authors:  Yosef Laviv; Burkhard Kasper; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2017-03-11       Impact factor: 3.042

3.  Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.

Authors:  Yong-Zhong Wang; You-Qing Cao; Jian-Nong Wu; Miao Chen; Xiao-Ying Cha
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.

Authors:  Asiye Safak Bulut; Esra Erden; Serpil Dizbay Sak; Hatice Doruk; Nazmiye Kursun; Dilek Dincol
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

5.  Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.

Authors:  Wei-Cheng Lu; Hui Xie; Ce Yuan; Jin-Jiang Li; Zhao-Yang Li; An-Hua Wu
Journal:  Cancer Cell Int       Date:  2020-08-28       Impact factor: 5.722

6.  Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: implications for glioma histogenesis and biology.

Authors:  Wootack Rhee; Sutapa Ray; Hideaki Yokoo; Megan E Hoane; Chong C Lee; Andrei M Mikheev; Philip J Horner; Robert C Rostomily
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

7.  Exogenous superoxide dismutase: action on liver oxidative stress in animals with streptozotocin-induced diabetes.

Authors:  Fábio Cangeri Di Naso; Alexandre Simões Dias; Marilene Porawski; Norma Anair Possa Marroni
Journal:  Exp Diabetes Res       Date:  2011-03-13

8.  Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study.

Authors:  Peng Zhao; Lin Zhao; Peng Zou; Ailin Lu; Ning Liu; Wei Yan; Chunsheng Kang; Zhen Fu; Yongping You; Tao Jiang
Journal:  BMC Cancer       Date:  2012-12-22       Impact factor: 4.430

9.  SjCa8, a calcium-binding protein from Schistosoma japonicum, inhibits cell migration and suppresses nitric oxide release of RAW264.7 macrophages.

Authors:  Ji Liu; Tong Pan; Xu You; Yiyue Xu; Jinyi Liang; Yanin Limpanont; Xi Sun; Kamolnetr Okanurak; Huanqin Zheng; Zhongdao Wu; Zhiyue Lv
Journal:  Parasit Vectors       Date:  2015-10-07       Impact factor: 3.876

10.  Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.

Authors:  Shuai Shen; Zihao Yan; Jianqi Wu; Xing Liu; Gefei Guan; Cunyi Zou; Qing Guo; Chen Zhu; Tianqi Liu; Chen Chen; Ling Chen; Peng Cheng; Wen Cheng; Anhua Wu
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.